Skip to main content
SpringerLink
Log in

Hauptthema: Herzinsuffizienz

  • Conference paper
Verhandlungen der Deutschen Gesellschaft für Innere Medizin

Part of the book series: Verhandlungen der Deutschen Gesellschaft für Innere Medizin ((VDGINNERE,volume 97))

  • 33 Accesses

Zusammenfassung

Eine Herzinsuffizienz ist durch das Unvermögen des Herzens als globales Pumporgan gekennzeichnet, eine ausreichende nutritive Organdurchblutung für die kardialen und extrakardialen Strombahngebiete aufrechtzuerhalten. Ätiologisch kommen koronare, myokardiale und extrakardiale Ursachen in Betracht, am häufigsten hypertensive und ischämische Herzerkrankungen sowie primäre und sekundäre Kardiomyopathien.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alpert N, Mulieri LA (1981) The utilization of energy by the myocardium hypertrophied secondary to pressure overload. In: Strauer BE (ed) The heart in hypertension. Springer, Berlin Heidelberg New York, pp 153–165

    Chapter  Google Scholar 

  2. Arnold-Schmiebusch H, Klepzig M, Staubesand J, Strauer BE (1986) Die morphologische Grundlage der arteriellen Wandspannung im Koronargefäßsystem bei SHR verglichen mit Wistar-Kyoto-Ratten (WKY): Eine licht-und elektronenmikroskopisch morphometrische Studie zur Mediawanddicke gedehnter Gefäße. Verh Anat Ges 80: 585–586

    Google Scholar 

  3. Bethge C, Motz W, von Hehn A, Strauer BE (1987) Ventricular arrhythmias in hypertensive heart disease with and without heart failure. J Cardiovasc Pharmacol 10, Suppl. 6: 119–128

    Google Scholar 

  4. Bretschneider HJ (1967) Aktuelle Probleme der Koronardurchblutung und des Myokardstoffwechsels. Regensburg Ärztl Fortbild 1: 11

    Google Scholar 

  5. Drayer JJM, Garding JM,Waber MS, Aronow WS (1983) Cardiac muscle mass during vasodilatation therapy of hypertension. Clin Pharmacol Ther 33: 727–732

    CAS  Google Scholar 

  6. Eisenlohr H, Schmiebusch H, Strauer BE (1988) Regression of medihypertrophy in hypertensive coronary resistance vessels by antihypertensive therapy. Circulation (Suppl. II) 78/ 4: 169

    Google Scholar 

  7. Ford LE (1976) Heart size. Circ Res 39: 297

    Article  CAS  Google Scholar 

  8. Fouad FM, Hakashima Y, Tarazi RC, Salcedo EE (1982) Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Am J Cardiol 49: 795–801

    Article  PubMed  CAS  Google Scholar 

  9. Frohlich ED (1981) Beta-adrenergic receptor blockade in the treatment of essential hypertension. In: Strauer BE (ed) The heart in hypertension. Springer, Berlin Heidelberg New York, pp 425–436

    Chapter  Google Scholar 

  10. James T (1977) Small arteries of the heart. Circulation 56: 2

    Article  PubMed  CAS  Google Scholar 

  11. Kannel WB, Sorlie P (1981) Left ventricular hypertrophy in hypertension: Prognostic and pathogenetic implications (The Framingham Study). In: Strauer BE (ed) The heart in hypertension. Springer, Berlin Heidelberg New York, pp 223: 242

    Google Scholar 

  12. Klepzig M, Eisenlohr H, Steindl S, Schmiebusch H, Strauer BE (1987) Media hypertrophy in hypertensive coronary resistance vessels. J Cardiovasc Pharmacol 10: 97–102

    Google Scholar 

  13. Kochsiek K, Heiss HW, Tauchert M, Strauer BE (1971) Koronarreserve and Sauerstoffverbrauch bei hypertrophischer obstruktiver Cardiomyopathie. Verh Dtsch Ges Inn Med 77: 880

    PubMed  CAS  Google Scholar 

  14. Leschke M, Vogt M, Motz W, Strauer BE (1990) Blood rheology as a contributing factor in reduced coronary reserve in systemic hypertension. Am J Cardiol 65: 56G - 59G

    Article  PubMed  CAS  Google Scholar 

  15. Linzbach AJ (1960) Heart failure from the point of view of quantitative anatomy. Am J Cardiol 5: 370

    Article  PubMed  CAS  Google Scholar 

  16. Linzbach AJ (1981) Structural adaption of the heart in hypertension and the physical consequences. In: Strauer BE (ed) The heart in hypertension. Springer, Berlin Heidelberg New York, pp 243–250

    Chapter  Google Scholar 

  17. McLenachan JM, Henderson E, Morris KI, Dargie HJ (1987) Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. H Engl J Med 317: 787–792

    Article  CAS  Google Scholar 

  18. Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED (1984) Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 77: 18–22

    Article  PubMed  CAS  Google Scholar 

  19. Motz W, Ringsgwandl G, Strauer BE (1984) Regression of left ventricular muscle mass and collagen following nifedipine therapy. Circulation 70: 237

    Google Scholar 

  20. Motz W, Strauer BE (1984) Regression of structural cardiovascular changes by antihypertensive therapy. Hypertension 6: 133–139

    Article  Google Scholar 

  21. Motz W, Strauer BE (1989) Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 13: 43–50

    Article  PubMed  CAS  Google Scholar 

  22. Motz W, Strauer BE (1990) Differential therapy of hypertensive heart disease. Am J Cardiol 65: 60G - 64G

    Article  PubMed  CAS  Google Scholar 

  23. Schwartzkopff B, Frenzel H, Vogt M, Motz W, Strauer BE (1989) Myocardial structure in patients with reduced coronary reserve in hypertensive heart disease. Circulalion (Suppl. 2) 4 /80: 532

    Google Scholar 

  24. Schwartzkopff B, Steg M, Lösse B, Scheler S, Motz W, Strauer BE (1990) Myokardischämie bei Patienten mit hypertropher Kardiomyopathie. Z Kardiol (Suppl. 1 ) 79: 83

    Google Scholar 

  25. Strauer BE (1972) Contractile response to morphine, piritramide, meperidine and fentanyl: a comparative study of effects on the isolated ventricular myocardium. Anesthesiology 387: 304

    Article  Google Scholar 

  26. Strauer BE, Kramer H, Avenhaus H, Bolte HD, Luderitz B, Neubaur J, Riecker G (1975) Hämodynamik, Volumina and Dehnbarkeit des linken Ventrikels bei 167 Patienten mit angeborenen and erworbenen Herzfehlern. Klin Wochenschr 53: 961

    Article  PubMed  CAS  Google Scholar 

  27. Strauer BE, Kramer H, Bolte HD, Riecker G (1975) Die Beziehungen zwischen Volumengrößen and Auswurffraktion des linken Ventrikels bei Mitral-and Aortenklappenregurgitation. Klin Wochenschr 53: 975

    Article  Google Scholar 

  28. Strauer BE (1975) Die hypertrophischeobstruktive Kardiomyopathie. Internist (Berlin) 16: 530

    CAS  Google Scholar 

  29. Strauer BE (1981) Koronare Mikrozirkulationsstörungen. Klin Wochenschr 59: 1125

    Article  PubMed  CAS  Google Scholar 

  30. Strauer BE (1977) Die quantitative Bestimmung der Koronarreserve in der Diagnostik koronarer Durchblutungsstörungen. Internist (Berlin) 18: 579

    CAS  Google Scholar 

  31. Strauer BE (1979) Myocardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy and coronary reserve. Am J Cardiol 44: 730

    Article  PubMed  CAS  Google Scholar 

  32. Strauer BE (1979) Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 44: 999

    Article  PubMed  CAS  Google Scholar 

  33. StrauerBE (1983) Left ventricular dynamics, energetics and coronary hemodynamics in hypertrophy heart disease. Eur Heart J (Suppl. A) 4: 137

    Article  Google Scholar 

  34. Strauer BE (1985) Progression and Regression der Herzhypertrophie beim arteriellen Bluthochdruck. Z Kardiol [Suppl. 7] 74…171–178

    Google Scholar 

  35. Strauer BE (1987) Structural and functional adaptation of the chronically overloaded heart in arterial hypertension. Am Heart J 114: 948–957

    Article  PubMed  CAS  Google Scholar 

  36. Strauer BE (1988) Coronary hemodynamics in hypertensive heart disease. Am J Med (Suppl. 3 ) 84: 45A - 53A

    Article  Google Scholar 

  37. Strauer BE (1990) Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am J Cardiol 65: 34–41

    Article  Google Scholar 

  38. Strauer BE (1990) The significance of coronary reserve in clinical heart disease. J Am Coll Cardiol 15: 775

    Article  PubMed  CAS  Google Scholar 

  39. Vogt M, Rabenau O, Motz W, Strauer BE (1989) Evidence of endothelial dysfunction in patients with angina pectoris and angiographically normal coronary arteries. Circulation (Suppl. 2) 4 /80: 436

    Google Scholar 

  40. Vogt M, Motz W, Scheler S, Strauer BE (1990) Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension. Am J Cardiol 65: 45G - 50G

    Article  PubMed  CAS  Google Scholar 

  41. Vogt M, Motz W, Schwartzkopff B, Strauer BE (1990) Coronary microangiopathy and cardiac hypertrophy. Eur Heart J ( Suppl. B) 11: 133–138

    Google Scholar 

  42. Vogt M, Motz W, Strauer BE (1990) Einfluß der linksventrikulären Hypertrophie auf die Einschränkung der koronaren Regulationsbreite bei Patienten mit arterieller Hypertonie. Klin Wochenschr (Suppl. 19 )

    Google Scholar 

  43. Vogt M, Scheler S, Motz W, Strauer BE (1990) Ventrikuläre Herzrhythmusstörungen bei Hypertonikern. Z Kardiol (Suppl. 1 ) 79: 103

    Google Scholar 

  44. Riegger AJG, Elsner D, Kromer EP (1989) Circulatory and renal control by prostaglandins and renin in low cardiac output in dogs. Am J Physiol 256: H1079 — H1086

    PubMed  CAS  Google Scholar 

  45. Elsner D, Kromer EP, Riegger AJG (1990) Effect of vagal blockade on neurohumoral systems in conscious dogs with heart failure. J Cardiovasc Pharmacol 15: 586–591

    Article  PubMed  CAS  Google Scholar 

  46. Riegger AJG, Elsner D, Kromer EP, Daffner C, Forssmann WG, Muders F, Pascher EW, Kochsiek K (1988) Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation 77: 398–406

    Article  PubMed  CAS  Google Scholar 

  47. Minotti JR, Johnson EC, Hudson TL, Zuroske G, Murata G, Fukushima E, Cagle TG, Chick TW, Massie BM, Icenogle MV (1990) Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest 86: 751–758

    Article  PubMed  CAS  Google Scholar 

  48. Hirsch AT, Pinto YM, Schunkert H, Dzau VJ (1990) Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol 66: 22D - 32D

    Article  PubMed  CAS  Google Scholar 

  49. Yanagisawa M, Kurihara H, Kimura S (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415

    Article  PubMed  CAS  Google Scholar 

  50. Rubanyi GM, Romero JC, Vanhoutte PM (1986) Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250: H1145 — H1149

    PubMed  CAS  Google Scholar 

  51. Elsner D, Müntze A, Kromer EP, Riegger AJG (1991) The systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure. Cardiovasc Res (in press)

    Google Scholar 

  52. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P (1987) Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57: 17–22

    Article  PubMed  CAS  Google Scholar 

  53. Beaune J (1989) Comparison of enalapril versus digoxin for congestive heart failure. Am J Cardiol 63: 22D - 25D

    Article  PubMed  CAS  Google Scholar 

  54. Böhm M, Beuckelmann D, Brown I, Feiler G, Lorenz B, Näbauer M, Kemkes B, Erdmann E (1988) Reduction of ß-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J 9: 844–852

    PubMed  Google Scholar 

  55. Böhm M, Mittmann C, Schwinger RHG, Erdmann E (1991) Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity. Am Heart J 120: 1381–1392

    Article  Google Scholar 

  56. Böhm M, Morano I, Pieske B, Rüegg JC, Wankerl M, Zimmermann R, Erdmann E (1990) Contribution of cAMP-Phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res 68: 689–701

    Article  Google Scholar 

  57. Böhm M, Reuschel-Janetschek E, Erdmann E (1990) Lack of sustained hemodynamic effects of the [32-adrenoceptor agonist dopexamine in end-stage congestive heart failure. Am J Cardiol 65: 395–396

    Article  PubMed  Google Scholar 

  58. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman S, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and ßadrenergic-receptor density in failing human hearts. New Engl J Med 307: 205–211

    Article  PubMed  CAS  Google Scholar 

  59. Brozena S, Jessup M (1990) Pathophysiologic strategy in the management of congestive heart failure. Ann Rev Med 41: 65–74

    Article  PubMed  CAS  Google Scholar 

  60. Captopril Multicenter Research Group (1983) A placebo-controlled trial of captopril in refractory chronic congestive heart failure. JACC 2: 755–763

    Article  Google Scholar 

  61. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R (1989) A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. New Engl J Med 320: 677–683

    Article  PubMed  CAS  Google Scholar 

  62. Erdmann E (1989) The value of positive inotropy in acute and chronic heart failure. J Cardiovasc Pharmacol 14, Suppl 3: S36 - S41

    Google Scholar 

  63. Erdmann E, Böhm M, Schwinger RHG, Beuckelmann DJ (1990) Neue Aspekte zur Pathogenese der Herzinsuffizienz. Internist 31: 632–640

    PubMed  CAS  Google Scholar 

  64. Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP (1987) Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75: 331–339

    Article  PubMed  CAS  Google Scholar 

  65. Fleg JL, Gottlieb SH, Lakatta EG (1982) Is digoxin really important in treatment of compensated heart failure? Am J Med 73: 244–250

    Article  PubMed  CAS  Google Scholar 

  66. Fleg JL, Lakatta EG (1984) How useful is digitalis in patients with congestive heart failure and sinus rhythm? Int J Cardiol 6: 295–305

    Article  PubMed  CAS  Google Scholar 

  67. Guyatt GH (1986) The treatment of heart failure. A methodological review of the literature. Drugs 32: 538–568

    Article  PubMed  CAS  Google Scholar 

  68. Guyatt GH, Sullivan MJJ, Fallen EL, Tihal H, Rideout E, Halcrow S, Nogradi S, Townsend M, Taylor W (1988) A controlled trial of digoxin in congestive heart failure. Am J Cardiol 61: 371–375

    Article  PubMed  CAS  Google Scholar 

  69. Henwood JM, Todd PA (1988) Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 36: 11–31

    Google Scholar 

  70. Jaeschke R, Oxman AD, Guyatt G (1990) To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systemic overview and meta-analysis. Am J Med 88: 279–286

    Article  PubMed  CAS  Google Scholar 

  71. Kelly RA (1990) Cardiac glycosides and congestive heart failure. Am J Cardiol 65: 10E - 16E

    Article  PubMed  CAS  Google Scholar 

  72. Kimmelstiel C, Benotti R (1988) How effective is digitalis in the treatment of congestive heart failure? Am Heart J 116: 1063–1070

    Article  PubMed  CAS  Google Scholar 

  73. Kostis JB, Lacy CR, Raia JJ, Dworkin JH, Warner RG, Casazza LA (1987) DPI 201–106 for severe congestive heart failure. Am J Cardiol 60: 1334–1339

    Article  PubMed  CAS  Google Scholar 

  74. Packer M (1988) Vasodilator and inotropic drugs for the treatment of chronic heart failure: distinguishing hype from hope. JACC 12: 1299–1317

    Article  PubMed  CAS  Google Scholar 

  75. Packer M, Medina N, Yushak M (1984) Hemodynamic and clinical limitations of long-therm inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation 70: 1038–1047

    Article  PubMed  CAS  Google Scholar 

  76. Schüren KP, Hüttemann U (1974) Chronisch obstruktive Lungenerkrankungen: Die hämodynamische Wirkung von Digitalis beim chronischen Cor pulmonale in Ruhe and unter Belastung. Klin Wschr 52: 736746

    Google Scholar 

  77. Schwinger RHG, Böhm M, Erdmann E (1990) Effectiveness of cardiac glycosides in human myocardium with and without “downregulated” (3-adrenoceptors. J Cardiovasc Pharmacol 15: 692–697

    Article  PubMed  CAS  Google Scholar 

  78. Schwinger RHG, Böhm M, Mittmann C, La Rosée K, Erdmann E (1991) Evidence for an enhanced effectiveness of sodium-channel activators in failing human myocardium. J Mol Cell Cardiol: in press

    Google Scholar 

  79. The Xamoterol in severe heart failures study group (1990) Xamoterol in severe heart failure. Lancet 136: 1–6

    Google Scholar 

  80. Thormann J, Kramer W, Kindler M, Neuss H, Bilgin Y, Schlepper M (1985) Wirkungsvergleich des neuen Kardiotonikums DPI 201–106 versus Dobutamin bei dilatativer Kardiomyopathie: Analyse durch Registrierung serieller Druck/ Volumen-Beziehungen und On-line-MVO2-Bestimmung. Herz Kreisl 11: 605–615

    Google Scholar 

  81. Unverferth DV, Blanford M, Kates RE, Leier CV (1980) Tolerance to dobutamine after a 72 hour continuons infusion. Am J Med 69: 262–266

    Article  PubMed  CAS  Google Scholar 

  82. Schröder JS (1979) Current status of cardiac transplantation. JAMA 241: 2

    Google Scholar 

  83. Bailey L, Nehlsen-Cannarella S, Doroshow R, Jacobson J, Martin R, Allard M, Hyde M, Bui R, Petry E (1976) Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome. N Engl J Med 315: 949

    Article  Google Scholar 

  84. Katz MR, Barnhart GR, Szentpetery S, Rider S, Thompson JA, Hess M, Hastillo A, Lower RR (1987) Are steroids essential for successful maintenance of immunosuppression in heart transplantation? J Heart Transplant 6: 293

    PubMed  CAS  Google Scholar 

  85. Hammer C, Reichenspurner H, Ertel W, Lersch C, Plahl M, Brendel W, Reichart B, Uberfuhr P, Welz A, Kemkes BM, Reble B, Funcius W, Gokel M (1984) Cytological and immunological monitoring of cyclosporine-treated human heart recipients. Heart Transplantation 3: 228

    Google Scholar 

  86. Burchert W, Kotzerke J, Heublein B, Albes J, Hundeshagen H: Diagnosis of heart transplant rejection by 111-In-antimyosin scintigraphy. In: Schmidt HAE, Chambron J (eds) Nuclear Medicine. Schattauer, Stuttgart, pp 179–181

    Google Scholar 

  87. Warnecke H, Schüler S, Goetze HJ, Mattheis G, Süthoff U, Müller J, Tietze U, Hetzer R (1986) Non-invasive monitoring of cardiac allograft rejection by intramyocardial electrogram recording. Circulation 74: 72

    Article  Google Scholar 

  88. Heublein B (1990) Texturveränderung unter besonderer Berücksichtigung der Abstoßungsreaktion bei Herztransplantierten. In: Berwing K, Schleppe K (Hrsg) Echokardiographie. Schattauer, Stuttgart

    Google Scholar 

  89. Opelz G (1989) Effect of HLA matching in heart transplantation. Transplant Proc 21: 794

    PubMed  CAS  Google Scholar 

  90. Heublein B, Haverich A, Borst HG (1990) Long-term follow-up after orthotopic heart transplantation. Thorac Cardiovasc Surgeon 38: 285

    Article  CAS  Google Scholar 

  91. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE (1990) Eight-year results of cyclosporine-treated patients with cardiac transplants. J Thorac Cardiovasc Surg 99: 500

    PubMed  CAS  Google Scholar 

  92. Kemnitz J, Heublein B, Haverich A (1990) Myopathische Form der chronischen Abstoßung im Herztransplantat. Verh Dtsch Ges Path 74: 618

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Köln, Deutschland

    H. H. Hilger

  2. Frankfurt/Main, Deutschland

    M. Kaltenbach

  3. Medizinische Klinik und Poliklinik B, Universität Düsseldorf, Deutschland

    B. E. Strauer

  4. Abteilung für Kardiologie, Pneumologie und Angiologie, Medizinische Klinik und Poliklinik B, Universität Düsseldorf, Deutschland

    H.-P. Schultheiß

  5. Medizinische Klinik, Universität Würzburg, Deutschland

    A. J. G. Riegger

  6. Abteilung Innere Medizin III — Kardiologie —, Medizinische Klinik, Universität Freiburg, Deutschland

    H. Just

  7. Medizinische Klinik I, Klinikum Großhadern, Universität München, Deutschland

    E. Erdmann

  8. Abteilung Innere Medizin III, Medizinische Klinik, Universität Heidelberg, Deutschland

    R. Dietz

  9. Klinik für Thorax-, Herz-und Gefäßchirurgie, Medizinischen Hochschule Hannover, Deutschland

    H. G. Borst, B. Heublein & A. Haverich

Authors
  1. H. H. Hilger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Kaltenbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. E. Strauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H.-P. Schultheiß
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. J. G. Riegger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Just
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Erdmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Dietz
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H. G. Borst
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. B. Heublein
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A. Haverich
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Humboldtstr. 14, W-6200, Wiesbaden, Germany

    Klaus Miehlke

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hilger, H.H. et al. (1991). Hauptthema: Herzinsuffizienz. In: Miehlke, K. (eds) Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 97. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84710-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84710-3_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-55080-8

  • Online ISBN: 978-3-642-84710-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation